Psoriasis

Disease Management and Clinical Outcomes

Volumn 1, Issue 6, 1998, Pages 195-202

  Gottlieb, A B ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPSORIASIS AGENT; BARBITURIC ACID DERIVATIVE; CALCIPOTRIOL; CORTICOSTEROID; CYCLOSPORIN A; DITHRANOL; ETRETIN; HLA C ANTIGEN; METHOTREXATE; PEPTIDE; PHENYLBUTAZONE; PHENYTOIN; PROBENECID; SALICYLIC ACID DERIVATIVE; SULFONAMIDE; TACROLIMUS; TAZAROTENE; VITAMIN D;

CLINICAL FEATURE; CLINICAL PROTOCOL; CORTICOSTEROID THERAPY; COST OF ILLNESS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ERYTHRODERMA; GENETIC SUSCEPTIBILITY; ONSET AGE; PATHOGENESIS; PATIENT REFERRAL; PREVALENCE; PSORIASIS; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; PUSTULOSIS PALMOPLANTARIS; REVIEW; TOPICAL DRUG ADMINISTRATION;

EID: 0032423677     PISSN: 10883371     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1088-3371(98)00025-4     Document Type: Review

References (34)

1. G.D. Weinstein J.G. Krueger An overview of psoriasis G.D. Weinstein A.B. Gottlieb Therapy of Moderate-to-Severe Psoriasis 1993 National Psoriasis Foundation Portland, OR 1 22
2. C. Gelmetti R. Caputo Psoriasis in childhood L. Dubertret Psoriasis 1994 ISED Brescia, Italy 248 260
3. J.N. Mansbridge A.M. Knapp Changes in keratinocyte maturation during wound healing J Invest Dermatol 89 1987 253 263
4. A.B. Gottlieb C.K. Chang D.N. Posnett B. Fanelli J.P. Tam Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes J Exp Med 167 1998 670 675
5. J.G. Krueger J.F. Krane D.M. Carter A.B. Gottlieb Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis J Invest Dermatol 94 1990 135S 140S
6. J.F. Krane A.B. Gottlieb D.M. Carter J.G. Krueger The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor I receptor J Exp Med 175 1992 1081 1090
7. B.J. Nickoloff The cytokine network in psoriasis Arch Dermatol 127 1991 871 884
8. G.D. Weinstein Methotrexate Diagnosis and treatment drugs five years later Ann Intern Med 86 1977 199 204
9. J.G. Krueger J.T. Wolfe R.T. Nabeya V.P. Vallat P. Gilleaudeau N.S. Heftler L.M. Austin A.B. Gottlieb Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells J Exp Med 182 1995 2057 2068
10. S.L. Gottlieb P. Gilleaudeau R. Johnson L. Estes T.G. Woodworth A.B. Gottlieb J.G. Krueger Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis Nat Med 1 1995 442 447
11. V.P. Vallat P. Gilleaudeau L. Battat J. Wolfe R. Nabeya N. Heftler E. Hodak A.B. Gottlieb J.G. Krueger PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis A possible cellular basis for remittive therapy J Exp Med 180 1994 283 296
12. J.G. Krueger A.B. Gottlieb Cellular signalling in psoriasis Growth factors, cytokines and eicosanoids L. Dubertret Psoriasis 1994 ISED Brescie, Italy 18 28
13. 3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis a placebo-controlled, double-blind study Br J Dermatol 131 1994 57 63
14. A.B. Gottlieb B. Lifshitz S.M. Fu L. Staiano–Coico C.Y. Wang D.M. Carter Expression of HLA-DR molecules by keratinocytes and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques J Exp Med 164 1986 1013 1028
15. A.B. Gottlieb Immunologic mechanisms in psoriasis J Am Acad Dermatol 18 1988 1376 1380
16. A.B. Gottlieb A.D. Luster D.N. Posnett D.M. Carter Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques J Exp Med 168 1988 941 948
17. A.B. Gottlieb J.G. Krueger HLA region genes and immune activation in the pathogenesis of psoriasis Arch Dermatol 126 1990 1083 1086
18. A.B. Gottlieb J.G. Krueger The role of activated T lymphocytes in the pathogenesis of psoriasis L. Dubertret Psoriasis 1994 ISED Brescie, Italy 63 71
19. B.S. Baker C.E.M. Griffiths S. Lambert A.V. Powles J.N. Leonard H. Valdimarsson L. Fry The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis Br J Dermatol 116 1987 503 510
20. J.K. Livden R. Nilsen J.R. Bjerke R. Matre In situ localization of interferons in psoriatic lesions Arch Dermatol Res 281 1989 392 397
21. K.D. Cooper Psoriasis Leukocytes and cytokines Dermatol Clin 8 1990 737 745
22. J.N. Barker G.D. Karabin T.J. Stoff V.J. Sarma V.M. Dixit B.J. Nickoloff Detection of interferon-gamma mRNA in psoriatic epidermis by polymerase chain reaction J Dermatol Sci 2 1991 106 111
23. C.N. Ellis M.S. Fradin J.M. Messana Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial N Engl J Med 324 1991 277 284
24. J.D. Bos M.M. Meinardi T. van Joos F. Huele A.V. Powles L. Fry Use of cyclosporin in psoriasis Lancet 2 1989 1500 1502
25. A.B. Gottlieb R.M. Grossman L. Khandke D.M. Carter P.B. Sehgal S.M. Fu A. Granelli–Piperno M. Rivas L. Barazani J.G. Krueger Studies of the effect of cyclosporine in psoriasis in vivo Combined effects on activated T lymphocytes and epidermal regenerative maturation J Invest Dermatol 98 1992 302 309
26. L. Khandke R. Ashinoff J.F. Krane L. Staiano–Coico A. Granelli-Piperno A.D. Luster D.M. Carter J.G. Krueger A.B. Gottlieb Cycloporine in psoriasis treatment Inhibition of keratinocyte cell-cycle progression in G1 independent of effects on transforming growth factor alpha/epidermal growth factor receptor pathways Arch Dermatol 127 1991 1172 1179
27. I. Lu P. Gilleaudeau J.A. McLane N. Heftler M. Kamber S. Gottlieb J.G. Krueger A.B. Gottlieb Modulation of epidermal differentiation, tissue inflammation, and T-lymphocyte infiltration in posoriatic plaques by topical calcitriol J Cutan Pathol 23 1996 419 430
28. S.L. Gottlieb E. Hayes P. Gilleaudeau I. Cardinale A.B. Gottlieb J.G. Krueger Cellular actions of etretinate in psoriasis Enhanced epidermal differentiation and reduced cell-mediated inflammation are unexpected outcomes J Cutaneous Pathol 23 1996 404 418
29. + Keratinocyte Arthritis Rheum 30 1987 901 907
30. J. Funk T. Langeland E. Schrumpf L.E. Hanssen Psoriasis induced by interferon-alpha Br J Dermatol 125 1991 463 465
31. G. Fierlbeck G. Rassner C. Muller Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations Arch Dermatol 126 1990 351 355
32. T. Poyner I.W. Hughes B.K. Dass P.I. Adnitt Long-term treatment of chronic plaque psoriasis with Calcipotriol J Dermatol Treat 4 1993 173 177
33. Katz HI, ed. Dermatologist’s guide to adverse therapeutic interactions. Philadelphia: Lippincott-Raven; 1997
34. G.C. Lee G.D. Weinstein Comparative cost-effectiveness of different treatments for psoriasis R. Rajagopalan E.F. Sheretz R.T. Anderson Care Management of Skin Diseases 1998 Marcel Dekker Life Quality and Economic Impact. New York 269 298